NLRP3 and breast cancer: Overall, these results suggest that DPP-4i can reprogram tumor microenvironment by direct interaction with BC cells via ROS–NF-кB–NLRP3 axis, offering novel insights relevant for the development of effective immunotherapeutic approaches to alleviate DPP-4i-driven BC metastasis.